| Symbiotec Pharmalab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544889 |
NSE Symbol : SYMBIOTEC |
P/E(TTM) : 48.16 |
|
ISIN Demat : INE899I01028 |
Div & Yield% : 0.00 |
EPS(TTM) : 22.70 |
|
Book Value(₹) : 195.23 |
Market Cap(₹Cr) : 7,024.80 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 756.68 | 673.61 | 563.59 | 633.85 | 622.86 |
| Other Income | 32.00 | 19.76 | 12.37 | 5.65 | 9.01 |
| Stock Adjustments | -11.91 | -6.33 | 14.78 | 1.52 | -2.29 |
| Total Income | 776.77 | 687.04 | 590.74 | 641.02 | 629.58 |
| EXPENDITURE : | |||||
| Raw Materials | 288.02 | 315.25 | 304.57 | 359.86 | 263.81 |
| Power and Fuel Cost | 29.13 | 31.17 | 28.75 | 27.56 | 24.57 |
| Other Manufacturing Expenses | 50.54 | 41.73 | 33.60 | 22.05 | 18.88 |
| Selling and Administration Expenses | 22.41 | 19.22 | 20.64 | 18.42 | 21.04 |
| Miscellaneous Expenses | 16.63 | 15.38 | 82.74 | 20.44 | 17.14 |
| Employee Benefit Expenses | 119.02 | 101.60 | 92.55 | 81.74 | 72.77 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 251.03 | 162.70 | 27.89 | 110.95 | 211.38 |
| Interest | 16.65 | 7.54 | 8.05 | 3.07 | 6.52 |
| Gross Profit | 234.38 | 155.16 | 19.84 | 107.88 | 204.86 |
| Depreciation | 38.36 | 37.26 | 27.62 | 25.11 | 22.18 |
| Profit Before Tax | 196.02 | 117.90 | -7.78 | 82.77 | 182.68 |
| Current Tax | 47.39 | 28.30 | 15.16 | 21.05 | 46.44 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.81 | 0.65 | -0.28 | 0.00 | 0.67 |
| Reported Net Profit | 145.83 | 88.95 | -22.66 | 61.73 | 135.56 |
| Extraordinary Items | 0.00 | 0.01 | -79.65 | 0.00 | 0.01 |
| Adjusted Net Profit | 145.83 | 88.94 | 56.99 | 61.73 | 135.55 |
| Adjustment below Net Profit | -0.48 | -0.62 | 0.29 | 0.10 | -0.04 |
| Profit/Loss Balance carried down | 589.07 | 500.75 | 523.11 | 461.29 | 325.77 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 734.43 | 589.07 | 500.75 | 523.11 | 461.29 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 133.35 | 81.33 | -20.72 | 56.45 | 123.96 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 832.83 | 695.99 | 615.23 | 635.68 | 579.15 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - |
